Skip to main content
Normal View

Healthcare Policy

Dáil Éireann Debate, Tuesday - 10 February 2026

Tuesday, 10 February 2026

Questions (979)

Claire Kerrane

Question:

979. Deputy Claire Kerrane asked the Minister for Health the financial supports available for a young person (details supplied), who requires surgery which cannot be performed in Ireland, the UK, Europe or Switzerland, and therefore, must travel to US.; and if she will make a statement on the matter. [9249/26]

View answer

Written answers

The HSE operates the EU Treatment Abroad Scheme (TAS), for persons entitled under EU Regulation 883/04. The TAS is a consultant led scheme and allows for an Ireland-based public consultant to refer a public patient who is normally resident in Ireland for treatment in the public healthcare system of another EU member state, the UK or Switzerland. Subject to the EU Regulations and Guidelines, the TAS provides for the cost of approved public treatments in another EU/EEA member state, the UK or Switzerland through the issue of form S2 (IE) where the treatment is:

• among the benefits provided for by Irish legislation;

• not available in Ireland;

• not available within the time normally necessary for obtaining it in Ireland, taking account of the patient's current state of health and the probable course of the disease;

• medically necessary and will meet the patient’s needs;

• a proven form of medical treatment and not experimental or test treatment;

• provided in a recognised public hospital or other institution that will accept EU/EEA form S2 (IE) and;

• is under the control of a registered medical practitioner.

The HSE provides further information for patients on the HSE TAS website: www2.hse.ie/services/schemes-allowances/treatment-abroad-scheme/

It is important to note that the EU Treatment Abroad Scheme facilitates patient to access planned healthcare in the public healthcare system of another EU/EEA member state, the UK or Switzerland.

Share